Future research should explore the effects of varying US frequencies and intensities on TRPV2 activation, as well as refine BG composition and structure to optimize ion release for more precise therapeutic outcomes, broadening its potential in cancer treatment. The gene discussed is TRPV2; the disease is cancer.